Why is biogerontology an important emerging field with respect to current disease research? The elderly popuation is afflicted with a plethora of pathologies and is statistically more likely to develop these afflictions (compared to younger individuals) by many orders of magnitude. Our current approach to treating pathologies in the elderly is to treat them for the specific diseases that ail them. However, if the leading cause of death for the elderly were cured tomorrow, this would have only a minimal effect on the remaining vitality and time left to these individuals. Such individuals would still be at a much greater risk for developing other age-related pathologies, so one might essentially be curing one patient's cancer one day so they can die of cardiovascular disease the next. This disposition towards age-related mortality is a reflection of the human body's progressive loss of mechanisms preserving homeostatic equilibrium. Thus, curing specific pathologies like heart disease or localized cancer could be completely superficial to the underlying deterioration of homeostatic mechanisms, the deterioration that actually leads to the myriad pathologies. If such common mechanisms in fact exist that predispose elderly people to the wide array of age-related pathologies, then investing in research into such putative mechanisms could be absolutely invaluable to the efficacious treatment of the growing elderly population. The discipline of biogerontology thus serves as a medium for elucidating the underlying mechanisms of aging and senescence that could prove so valuable to practical geriatric medicine.